Deependra Kumar Singh

Discovery of 3-Arylcoumarin-tetracyclic Tacrine Hybrids as Multifunctional Agents against Parkinson’s Disease

Koneni V. Sashidhara, Ram K. Modukuri, Pooja Jadiya et al. · ACS Medicinal Chemistry Letters · 2014 · 44 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Pharmacophore-Based Screening and Identification of Novel Human Ligase I Inhibitors with Potential Anticancer Activity

Shagun Krishna, Deependra Kumar Singh, Sanjeev Meena et al. · Journal of Chemical Information and Modeling · 2014 · 42 citations

Medicine, Medicinal Chemistry, Oncology +14

Identification of human flap endonuclease 1 (FEN1) inhibitors using a machine learning based consensus virtual screening

Amit Laxmikant Deshmukh, Sharat Chandra, Deependra Kumar Singh et al. · Molecular BioSystems · 2017 · 35 citations

Pharmacy, Medicinal Chemistry, Oncology +17

A Novel Benzocoumarin-Stilbene Hybrid as a DNA ligase I inhibitor with in vitro and in vivo anti-tumor activity in breast cancer models

Mohd Kamil Hussain, Deependra Kumar Singh, Akhilesh Singh et al. · Scientific Reports · 2017 · 28 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery of monocarbonyl curcumin hybrids as a novel class of human DNA ligase I inhibitors: in silico design, synthesis and biology

Dhanaraju Mandalapu, Deependra Kumar Singh, Sonal Gupta et al. · RSC Advances · 2016 · 16 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16